DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

Commit To Purchase Neurocrine Biosciences At $11, Earn 23.9% Annualized Using Options

Heavy Trading On Neurocrine Biosciences (NBIX) Before Market Open

US Stock Futures Tumble Ahead Of Durable-Goods Orders, Jobless Claims Data

Fundamentals Continue To Look Strong At Neurocrine Bio

Neurocrine Biosciences' CEO Discusses Q4 2013 Results - Earnings Call Transcript

Can You Still Ride This Month's 3 Biggest Winners To Greater Gains?

Biotech dominates in January as Intercept, Cell Therapeutics, and Neurocrine all surge after good drug-trial news.

Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside

3 Stocks to Get on Your Watchlist

A big-box retail giant, an up-and-coming developer of a tardive dyskinesia treatment, and a short-sale candidate.

It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013

Insider Trading Alert - NDSN, FNSR, NUVA, DECK And NBIX Traded By Insiders

See More Articles...